Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
75.19%
↑ 108% vs avg
Percentile
P86
Within normal range
Streak
2 yr
Consecutive growthAccelerating
Average
-942.30%
Historical baseline
PeriodValue
202575.19%
2024-14.77%
2023-70.45%
2022-15.70%
2021-82.20%
2020-133.79%
2019236.95%
201824.44%
20170.35%
2016-9442.98%